产品描述: | Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus. |
靶点: |
GLP-1 receptor;GlucagonReceptor |
参考文献: |
1. Wang Y,et al. Transformation of oligomers of lipidated peptide induced by change in pH.Mol Pharm. 2015 Feb 2;12(2):411-9. 2. Wang YG, et al. Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway.J Geriatr Cardiol. 2015 Jul;12(4):410-416. |
溶解性: |
H2O : 9.09 mg/mL (2.42 mM; ultrasonic and adjust pH to 3 with HCl) |
保存条件: |
-20℃ |
配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
1 mM |
0.267 ml |
1.333 ml |
2.666 ml |
5 mM |
0.053 ml |
0.267 ml |
0.533 ml |
10 mM |
0.027 ml |
0.133 ml |
0.267 ml |
50 mM |
0.005 ml |
0.027 ml |
0.053 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |